Literature DB >> 17625113

Functional data analysis applied to a randomized controlled clinical trial in hemodialysis patients describes the variability of patient responses in the control of renal anemia.

Robert M West1, Katie Harris, Mark S Gilthorpe, Cae Tolman, Eric J Will.   

Abstract

The achievement of desirable hemoglobin levels in renal anemia that is treated with epoetins is often incomplete and subject to much variation of outcome values and applied dosage. The further development of clinical decision support for renal anemia requires the characterization of patient responses and an analysis of the dynamics of the dosage and response variables. In this methodologic article, the extended data of a randomized, controlled clinical trial comparing two epoetins were examined by the techniques of functional data analysis to establish how precisely the patterns of treatment response might be described and analyzed. The description of the trajectory of hemoglobin values in each patient as a mathematical function allowed the characterization of individual responses, with a wide variety of patterns being revealed. An analysis of the degree of system control in the management of the anemia was then possible through phase plotting. The analysis also allowed an expression of the dynamic characteristics of the entire experimental system, analyzed in summary group waveforms with standard statistical properties. In addition, a quantification of the notional instability of patient responses enabled the determination of a subset of patients for whom control might be improved in a modified management system. It is concluded that functional data analysis does provide the basis for further characterization and experimental study of the control of renal anemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17625113     DOI: 10.1681/ASN.2006050436

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  12 in total

1.  Applying Functional Data Analysis to Assess Tele-Interpersonal Psychotherapy's Efficacy to Reduce Depression.

Authors:  Henok Woldu; Timothy G Heckman; Andreas Handel; Ye Shen
Journal:  J Appl Stat       Date:  2018-05-04       Impact factor: 1.404

2.  The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin.

Authors:  Bruno Watschinger; Hermann Salmhofer; Sabine Horn; Ulrich Neyer; Tatjana Wiesinger; Martin Wiesholzer; Helmut Erb; Christine Jaeger; Margit Hemetsberger; Alexander R Rosenkranz
Journal:  Wien Klin Wochenschr       Date:  2013-01-09       Impact factor: 1.704

3.  Randomized trial of model predictive control for improved anemia management.

Authors:  Michael E Brier; Adam E Gaweda; Andrew Dailey; George R Aronoff; Alfred A Jacobs
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

4.  Hemoglobin variability with epoetin beta and continuous erythropoietin receptor activator in patients on peritoneal dialysis.

Authors:  Nicholas M Selby; Sally A Fonseca; Richard J Fluck; Maarten W Taal
Journal:  Perit Dial Int       Date:  2011-11-01       Impact factor: 1.756

5.  Computerized decision support for EPO dosing in hemodialysis patients.

Authors:  Dana C Miskulin; Daniel E Weiner; Hocine Tighiouart; Vladimir Ladik; Karen Servilla; Philip G Zager; Alice Martin; H K Johnson; Klemens B Meyer
Journal:  Am J Kidney Dis       Date:  2009-09-25       Impact factor: 8.860

6.  Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality.

Authors:  Neil C Boudville; Ognjenka Djurdjev; Iain C Macdougall; Angel L M de Francisco; Gilbert Deray; Anatole Besarab; Paul E Stevens; Rowan G Walker; Pablo Ureña; Pablo Iñigo; Roberto Minutolo; Yosef S Haviv; Karen Yeates; Marisa L Agüera; Jennifer M MacRae; Adeera Levin
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 8.237

7.  Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients.

Authors:  Steven M Brunelli; Katherine E Lynch; Elizabeth D Ankers; Marshall M Joffe; Wei Yang; Ravi I Thadhani; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

Review 8.  Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.

Authors:  Suetonia C Palmer; Valeria Saglimbene; Dimitris Mavridis; Georgia Salanti; Jonathan C Craig; Marcello Tonelli; Natasha Wiebe; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2014-12-08

Review 9.  Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients.

Authors:  Deirdre Hahn; June D Cody; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2014-05-28

Review 10.  Applications of functional data analysis: A systematic review.

Authors:  Shahid Ullah; Caroline F Finch
Journal:  BMC Med Res Methodol       Date:  2013-03-19       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.